SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000110
Filing Date
2019-11-06
Accepted
2019-11-06 16:10:33
Documents
19
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201911068xkdoc.htm 8-K 34106
2 PRESS RELEASE pdli-201911068xkex991.htm EX-99.1 250704
3 PRESENTATION pdli-201911068xkex992.htm EX-99.2 6797
4 INFORMATION SHEET pdli-201911068xkex993.htm EX-99.3 213528
5 pdllogoa29.jpg GRAPHIC 123123
6 slide1b12.jpg GRAPHIC 48157
7 slide2b11.jpg GRAPHIC 199449
8 slide3b11.jpg GRAPHIC 115428
9 slide4b11.jpg GRAPHIC 136399
10 slide5b11.jpg GRAPHIC 160307
11 slide6b11.jpg GRAPHIC 146436
12 slide7b11.jpg GRAPHIC 109360
13 slide8b09.jpg GRAPHIC 104453
14 slide9b08.jpg GRAPHIC 94847
15 slidx26.jpg GRAPHIC 179009
16 slidx27.jpg GRAPHIC 158272
17 slidx28.jpg GRAPHIC 107300
18 slidx29.jpg GRAPHIC 89719
19 slidx30.jpg GRAPHIC 30982
  Complete submission text file 0000882104-19-000110.txt   2991046
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 191196392
SIC: 2836 Biological Products, (No Diagnostic Substances)